These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9764578)

  • 1. Establishment of a retinoic acid-resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM-CSF) transgenic severe combined immunodeficiency (SCID) mice.
    Fukuchi Y; Kizaki M; Kinjo K; Awaya N; Muto A; Ito M; Kawai Y; Umezawa A; Hata J; Ueyama Y; Ikeda Y
    Br J Cancer; 1998 Oct; 78(7):878-84. PubMed ID: 9764578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.
    Kizaki M; Matsushita H; Takayama N; Muto A; Ueno H; Awaya N; Kawai Y; Asou H; Kamada N; Ikeda Y
    Blood; 1996 Sep; 88(5):1824-33. PubMed ID: 8781440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review).
    Kizaki M; Fukuchi Y; Ikeda Y
    Int J Mol Med; 1999 Oct; 4(4):359-64. PubMed ID: 10493975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice.
    Zhang SY; Zhu J; Chen GQ; Du XX; Lu LJ; Zhang Z; Zhong HJ; Chen HR; Wang ZY; Berger R; Lanotte M; Waxman S; Chen Z; Chen SJ
    Blood; 1996 Apr; 87(8):3404-9. PubMed ID: 8605358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of human granulocyte-macrophage colony stimulating factor producing transgenic SCID mice.
    Miyakawa Y; Fukuchi Y; Ito M; Kobayashi K; Kuramochi T; Ikeda Y; Takebe Y; Tanaka T; Miyasaka M; Nakahata T; Tamaoki N; Nomura T; Ueyama Y; Shimamura K
    Br J Haematol; 1996 Dec; 95(3):437-42. PubMed ID: 8943881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
    Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T
    Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells.
    Witcher M; Shiu HY; Guo Q; Miller WH
    Blood; 2004 Nov; 104(10):3335-42. PubMed ID: 15256426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acute myeloblastic leukemia-ascites model using the human GM-CSF- and IL-3-releasing transgenic SCID mice.
    Fukuchi Y; Miyakawa Y; Kizaki M; Umezawa A; Shimamura K; Kobayashi K; Kuramochi T; Hata J; Ikeda Y; Tamaoki N; Nomura T; Ueyama Y; Ito M
    Ann Hematol; 1999 May; 78(5):223-31. PubMed ID: 10391103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte-macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemia.
    Hall PD; Willingham MC; Kreitman RJ; Frankel AE
    Leukemia; 1999 Apr; 13(4):629-33. PubMed ID: 10214872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells.
    Sakashita A; Nakamaki T; Tsuruoka N; Honma Y; Hozumi M
    Leukemia; 1991 Jan; 5(1):26-31. PubMed ID: 1705636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of PML/RARalpha impairs myelopoiesis.
    Early E; Moore MA; Kakizuka A; Nason-Burchenal K; Martin P; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7900-4. PubMed ID: 8755574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.
    Westervelt P; Pollock JL; Oldfather KM; Walter MJ; Ma MK; Williams A; DiPersio JF; Ley TJ
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9468-73. PubMed ID: 12077315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine dependent growth of human TF-1 leukemic cell line in human GM-CSF and IL-3 producing transgenic SCID mice.
    Fukuchi Y; Miyakawa Y; Kobayashi K; Kuramochi T; Shimamura K; Tamaoki N; Nomura T; Ueyama Y; Ito M
    Leuk Res; 1998 Sep; 22(9):837-43. PubMed ID: 9716016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-colony stimulating factor and retinoic acid cooperatively induce granulocyte differentiation of acute promyelocytic leukemia cells in vitro.
    Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
    Jpn J Cancer Res; 1989 Nov; 80(11):1077-82. PubMed ID: 2481663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.